Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: A meta-analysis

Molecular Biology Reports

Volumn 39, Issue 11, 2012, Pages 9921-9930

  Sergentanis, Theodoros N ^a,b   Economopoulos, Konstantinos P ^a,b   Choussein, Souzana ^a,b   Vlahos, Nikos F ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Society of Junior Doctors   (Greece)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytochrome P450 1A1; Ile462Val polymorphism; MspI polymorphism; Ovarian cancer; Thr461Asn polymorphism

Indexed keywords

CYTOCHROME P450 1A1;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CYP1A1 GENE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; OVARY CANCER; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84869490261     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1860-0     Document Type: Article

References (27)

1. Androutsopoulos VP, Tsatsakis AM, Spandidos DA (2009) Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer 9:187
2. Spink DC, Eugster HP, Lincoln DW II, Schuetz JD, Schuetz EG, Johnson JA, Kaminsky LS, Gierthy JF (1992) 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo- p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch Biochem Biophys 293: 342-348
3. Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, Garte SJ (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15: 2961-2963
4. Shi X, Zhou S, Wang Z, Zhou Z (2008) CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 59: 155-163
5. Zhuo WL, Zhang YS, Wang Y, Zhuo XL, Zhu B, Cai L, Chen ZT (2009) Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses. Arch Med Res 40: 169-179
6. Sergentanis TN, Economopoulos KP (2010) Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 122: 459-469
7. Sergentanis TN, Economopoulos KP, Choussein S, Vlahos NF (2011) Cytochrome P450 1A1 gene polymorphisms and endometrial cancer risk: a meta-analysis. Int J Gynecol Cancer 21: 323-331
8. Economopoulos KP, Choussein S, Vlahos NF, Sergentanis TN (2010) GSTM1, GSTT1 polymorphisms and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer 20: 1576-1580
9. Cavalli-Sforza LL, Piazza A, Menozzi P, Mountain J (1988) Reconstruction of human evolution: bringing together genetic, archaeological, and linguistic data. Proc Natl Acad Sci USA 85: 6002-6006
10. Higgins JPT, Green S (2010) Cochrane handbook for systematic reviews of interventions version 5.0.1. The Cochrane Collaboration, 2008. Available from: http://www.cochrane-handbook.org. Accessed 15 June 2010
11. Sergentanis TN, Economopoulos KP (2010) GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121: 195-202
12. Economopoulos KP, Sergentanis TN, Vlahos NF (2010) GSTM1, GSTT1, GSTP1 polymorphisms and ovarian cancer risk: a metaanalysis. Int J Gynecol Cancer 20: 732-737
13. Sergentanis TN, Economopoulos KP (2011) Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls. Mol Biol Rep 38: 4955-4963
14. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24: 1291-1306
15. Mikhailova ON, Gulyaeva LF, Prudnikov AV, Gerasimov AV, Krasilnikov SE (2006) Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk. Pharmacogenomics J 6: 189-193
16. Gulyaeva LF, Mikhailova ON, PustyInyak VO, Kim IVt, Gerasimov AV, Krasilnikov SE, Filipenko ML, Pechkovsky EV (2008) Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia. Adv Exp Med Biol 617: 359-366
17. Kotsopoulos J, Vitonis AF, Terry KL, De Vivo I, Cramer DW, Hankinson SE, Tworoger SS (2009) Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer. Cancer Causes Control 20: 335-344
18. Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, Guo C, Le Marchand L (2001) Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomark Prev 10: 209-216
19. Aktas D, Guney I, Alikasifoglu M, Yuce K, Tuncbilek E, Ayhan A (2002) CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm. Gynecol Oncol 86: 124-128
20. Sugawara T, Nomura E, Sagawa T, Sakuragi N, Fujimoto S (2003) CYP1A1 polymorphism and risk of gynecological malignancy in Japan. Int J Gynecol Cancer 13: 785-790
21. Terry KL, Titus-Ernstoff L, Garner EO, Vitonis AF, Cramer DW (2003) Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk. Cancer Epidemiol Biomark Prev 12: 187-190
22. Sellers TA, Schildkraut JM, Pankratz VS, Vierkant RA, Fredericksen ZS, Olson JE, Cunningham J, Taylor W, Liebow M, McPherson C, Hartmann LC, Pal T, Adjei AA (2005) Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Cancer Epidemiol Biomark Prev 14: 2536-2543
23. Seremak-Mrozikiewicz A, Drews K, Semczuk A, Jakowicki JA, Mrozikiewicz PM (2005) CYP1A1 alleles in female genital cancers in the Polish population. Eur J Obstet Gynecol Reprod Biol 118: 246-250
24. Holt SK, Rossing MA, Malone KE, Schwartz SM, Weiss NS, Chen C (2007) Ovarian cancer risk and polymorphisms involved in estrogen catabolism. Cancer Epidemiol Biomarkers Prev 16: 481-489
25. Delort L, Chalabi N, Satih S, Rabiau N, Kwiatkowski F, Bignon YJ, Bernard-Gallon DJ (2008) Association between genetic polymorphisms and ovarian cancer risk. Anticancer Res 28: 3079-3081
26. Heubner M, Wimberger P, Riemann K, Kasimir-Bauer S, Otterbach F, Kimmig R, Siffert W (2010) The CYP1A1 Ile462Val polymorphism and platinum resistance of epithelial ovarian neoplasms. Oncol Res 18: 343-347
27. Rohlfs RV, Weir BS (2008) Distributions of Hardy-Weinberg equilibrium test statistics. Genetics 180: 1609-1616